73.24
price up icon4.85%   3.39
after-market After Hours: 73.24
loading

Vaxcyte Inc Stock (PCVX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
41.80%
114.47
196.68 113.03 87.15 71.19
Depreciation and Amortization
11.11%
1.00
0.90 0.80 0.80 0.70
Operating Income/Loss
41.80%
-114.47
-196.68 -113.03 -87.15 -71.19
Income/Loss From Continuing Operations Before Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Net Income/Loss
47.44%
-95.02
-180.80 -92.66 -68.34 -60.46
Preferred Stock Dividends And Other Adjustments
100.00%
-
442.93 -185.33 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Diluted Average Shares
6,140%
111.69
1.7899 101.67 98.06 86.21
Basic Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Diluted Earnings Per Share
53.30%
-0.85
-1.82 -0.91 -0.70 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
442.93 -185.33 - -
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):